We are live on ! Find out more
Sanders Capital

Sanders Capital Portfolio holdings

AUM $99.8B
1-Year Est. Return 47.9%
This Fund
S&P 500
This Quarter Est. Return
-4.21%
1 Year Est. Return
+47.9%
3 Year Est. Return
+147.14%
5 Year Est. Return
+192.43%
10 Year Est. Return
+815.46%
AUM
$46B
AUM Growth
-$3.03B
Cap. Flow
+$79.2M
Cap. Flow %
0.17%
Top 10 Hldgs %
65.9%
Holding
46
New
2
Increased
24
Reduced
15
Closed
2
Avg Time Held
19.4 quarters
Top 10 Avg Time Held
14.1 quarters
Top 20 Avg Time Held
15 quarters

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$723M
2
SWK icon
Stanley Black & Decker
SWK
+$211M
3
DHI icon
D.R. Horton
DHI
+$136M
4
LEN icon
Lennar Class A
LEN
+$32M
5
TSM icon
TSMC
TSM
+$15.5M

Sector Composition

Rank Sector Weight
1 Technology 31.19%
2 Healthcare 26.37%
3 Communication Services 15.23%
4 Financials 7.81%
5 Consumer Staples 5.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GOOG icon
1
Alphabet (Google) Class C
GOOG
$4.27T
$4.58B 9.96%
32,804,780
+67,200
+0.2% +$9.14M
2016 Q3
22 quarters
TSM icon
2
TSMC
TSM
$2.31T
$4.34B 9.44%
41,631,855
-132,590
-0.3% -$15.5M
2014 Q3
30 quarters
UNH icon
3
UnitedHealth
UNH
$339B
$3.55B 7.72%
6,963,063
+44,640
+0.6% +$21.5M
2013 Q2
35 quarters
MU icon
4
Micron Technology
MU
$1.08T
$3.27B 7.1%
41,921,490
+646,950
+2% +$55.2M
2018 Q4
13 quarters
MSFT icon
5
Microsoft
MSFT
$4.04T
$3.05B 6.63%
9,888,812
+34,790
+0.4% +$10.5M
2013 Q2
35 quarters
AAPL icon
6
Apple
AAPL
$4.98T
$2.85B 6.2%
16,334,506
+19,160
+0.1% +$3.22M
2013 Q3
34 quarters
HCA icon
7
HCA Healthcare
HCA
$99.8B
$2.44B 5.31%
9,746,360
+298,323
+3% +$74.9M
2020 Q2
7 quarters
META icon
8
Meta Platforms (Facebook)
META
$1.94T
$2.42B 5.26%
10,882,194
+481,760
+5% +$120M
2018 Q3
14 quarters
ELV icon
9
Elevance Health
ELV
$92.2B
$2.01B 4.36%
4,081,861
+39,260
+1% +$17.9M
2013 Q2
35 quarters
CI icon
10
Cigna
CI
$74.7B
$1.79B 3.9%
7,479,977
+21,880
+0.3% +$5.12M
2013 Q2
35 quarters
MDT icon
11
Medtronic
MDT
$119B
$1.5B 3.26%
13,517,677
+1,687,707
+14% +$178M
2013 Q2
35 quarters
NOC icon
12
Northrop Grumman
NOC
$68.4B
$1.49B 3.23%
3,325,460
+596,760
+22% +$246M
2021 Q3
2 quarters
PG icon
13
Procter & Gamble
PG
$355B
$1.3B 2.82%
8,476,303
+77,920
+0.9% +$12.2M
2021 Q2
3 quarters
VEU icon
14
Vanguard FTSE All-World ex-US ETF
VEU
$67.9B
$1.23B 2.68%
21,380,131
+683,580
+3% +$40.2M
2013 Q2
35 quarters
WFC icon
15
Wells Fargo
WFC
$244B
$1.19B 2.59%
24,540,915
+1,390
+0% +$74.4K
2018 Q2
15 quarters
JPM icon
16
JPMorgan Chase
JPM
$881B
$1.18B 2.57%
8,682,576
+50,980
+0.6% +$7.53M
2013 Q2
35 quarters
PEP icon
17
PepsiCo
PEP
$173B
$1.13B 2.46%
6,768,680
+77,140
+1% +$13M
2017 Q1
20 quarters
SU icon
18
Suncor Energy
SU
$88B
$1.08B 2.35%
33,156,891
-65,950
-0.2% -$1.96M
2018 Q2
15 quarters
C icon
19
Citigroup
C
$209B
$1.01B 2.2%
18,951,546
-87,980
-0.5% -$5.43M
2013 Q2
35 quarters
HAL icon
20
Halliburton
HAL
$27.3B
$784M 1.7%
20,693,840
-6,550
-0% -$212K
2017 Q4
17 quarters
SPY icon
21
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$675M 1.47%
1,495,490
+232,530
+18% +$104M
2013 Q2
35 quarters
JNJ icon
22
Johnson & Johnson
JNJ
$599B
$636M 1.38%
3,588,230
-16,710
-0.5% -$2.84M
2020 Q4
5 quarters
STX icon
23
Seagate
STX
$170B
$471M 1.02%
5,240,802
+1,242,350
+31% +$127M
2021 Q3
2 quarters
DHI icon
24
D.R. Horton
DHI
$37.9B
$396M 0.86%
5,316,344
-1,563,149
-23% -$136M
2013 Q4
33 quarters
WDC icon
25
Western Digital
WDC
$143B
$361M 0.78%
9,606,116
+1,406,349
+17% +$57.7M
2021 Q3
2 quarters

Similar funds

Sanders Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Sanders Capital held 46 positions worth $46B, down 6.2% from $49B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Sanders Capital's Q1 2022 filing shows 2 new, 24 increased, 15 reduced and 2 closed positions. Its largest new stake was Novartis: 1,136,640 shares worth $99.7M. The largest sale was Pfizer, an estimated $723M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Healthcare and Communication Services.

  • Sanders Capital's largest Q1 2022 buy was Novartis: 1,136,640 shares worth $99.7M.
  • Sanders Capital added most to Northrop Grumman in Q1 2022, an estimated $246M increase.
  • Sanders Capital's biggest Q1 2022 reduction was D.R. Horton, cutting an estimated $136M.
  • Sanders Capital fully exited Pfizer in Q1 2022, selling an estimated $723M.
  • Sanders Capital's ten largest holdings make up 66% of its $46B portfolio in Q1 2022.
  • Sanders Capital opened 2 new positions and closed 2 in Q1 2022.
  • Sanders Capital's portfolio value fell 6.2% quarter-over-quarter to $46B.

Based on Sanders Capital's 13F filing for Q1 2022, filed 20 May 2022.